[20200604]IF10875_阿片类药物成瘾药物辅助治疗（MAT）的医疗保险覆盖范围 .pdf

https:/crsreports.congress.gov Updated June 4, 2020Medicare Coverage of Medication Assisted Treatment (MAT) for Opioid Addiction Medicare covers certain reasonable and necessary services provided by Medicare-enrolled health care practitioners for treating substance abuse disorders, such as alcoholism and opioid and other drug abuse. Medication Assisted Treatment (MAT) combines medication with counseling and behavioral therapies to provide comprehensive substance abuse treatment. Congress and the federal government have taken steps to increase the availability of MAT in response to a sharp increase in U.S. opioid overdoses and deaths in recent years. Effective January 1, 2020, the Support for Patients and Communities Act (SUPPORT; P.L. 115-271) added a Medicare benefit category for treating opioid use disorder, which includes comprehensive MAT services provided in the roughly 1,700 Substance Abuse Mental Health Services Administration (SAMHSA)-certified Opioid Treatment Programs (OTPs), also known as methadone clinics. OTP services include management, care coordination, psychotherapy, and counseling, as well as telehealth services and dispensing and administration of MAT drugs, inc